[Measurements of regional brain blood flow using xenon 133 before and after intravenous administration of the so-called vasoactive and cerebral-metabolism-active drugs in acute experiment].
D001921:Brain / Q000378:metabolism*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D000431:Ethanol / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology; D005663:Furans / Q000494:pharmacology; D006801:Humans; D009281:Naphthalenes / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D010847:Picolines / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D011868:Radioisotopes; D012039:Regional Blood Flow; D013440:Sulfides / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014748:Vinca Alkaloids / Q000494:pharmacology; D014978:Xenon
D005021:Ethylamines; D005663:Furans; D009281:Naphthalenes; D009539:Nicotinic Acids; D010847:Picolines; D011422:Propionates; D011868:Radioisotopes; D013440:Sulfides; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; D014978:Xenon; D000431:Ethanol; D013806:Theophylline
Messungen der regionalen Hirndurchblutung mit Xenon 133 vor und nach intravenöser Verabfolgung verschiedener sogenannter vasoaktiver und zerebralstoffwechselaktiver Pharmaka im Akutversuch.